486 related articles for article (PubMed ID: 35216753)
1. Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study.
Sarvestany SS; Kwong JC; Azhie A; Dong V; Cerocchi O; Ali AF; Karnam RS; Kuriry H; Shengir M; Candido E; Duchen R; Sebastiani G; Patel K; Goldenberg A; Bhat M
Lancet Digit Health; 2022 Mar; 4(3):e188-e199. PubMed ID: 35216753
[TBL] [Abstract][Full Text] [Related]
2. A deep learning framework for personalised dynamic diagnosis of graft fibrosis after liver transplantation: a retrospective, single Canadian centre, longitudinal study.
Azhie A; Sharma D; Sheth P; Qazi-Arisar FA; Zaya R; Naghibzadeh M; Duan K; Fischer S; Patel K; Tsien C; Selzner N; Lilly L; Jaeckel E; Xu W; Bhat M
Lancet Digit Health; 2023 Jul; 5(7):e458-e466. PubMed ID: 37210229
[TBL] [Abstract][Full Text] [Related]
3. Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy-confirmed NAFLD.
Feng G; Zheng KI; Li YY; Rios RS; Zhu PW; Pan XY; Li G; Ma HL; Tang LJ; Byrne CD; Targher G; He N; Mi M; Chen YP; Zheng MH
J Hepatobiliary Pancreat Sci; 2021 Jul; 28(7):593-603. PubMed ID: 33908180
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
[TBL] [Abstract][Full Text] [Related]
5. Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.
Chin J; Powell LW; Ramm LE; Hartel GF; Olynyk JK; Ramm GA
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1459-1468.e5. PubMed ID: 32745684
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
[TBL] [Abstract][Full Text] [Related]
7. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
8. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
Huang C; Seah JJ; Tan CK; Kam JW; Tan J; Teo EK; Kwek A; Wong YJ; Tan M; Ang TL; Kumar R
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101528. PubMed ID: 33268036
[TBL] [Abstract][Full Text] [Related]
9. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study.
Hashem A; Awad A; Shousha H; Alakel W; Salama A; Awad T; Mabrouk M
Arab J Gastroenterol; 2021 Jun; 22(2):88-92. PubMed ID: 33985905
[TBL] [Abstract][Full Text] [Related]
10. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis.
Sharma P; Dhawan S; Bansal R; Tyagi P; Bansal N; Singla V; Kumar A; Matin A; Arora A
Indian J Gastroenterol; 2014 Sep; 33(5):445-51. PubMed ID: 25138787
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
[TBL] [Abstract][Full Text] [Related]
13. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
Zhu X; Wang LC; Chen EQ; Chen XB; Chen LY; Liu L; Lei XZ; Liu C; Tang H
Dig Dis Sci; 2011 Sep; 56(9):2742-9. PubMed ID: 21399926
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
16. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
17. Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.
Shiha G; Soliman R; Mikhail NNH; Alswat K; Abdo A; Sanai F; Derbala MF; Örmeci N; Dalekos GN; Al-Busafi S; Hamoudi W; Sharara AI; Zaky S; El-Raey F; Mabrouk M; Marzouk S; Toyoda H
Hepatol Res; 2022 Feb; 52(2):165-175. PubMed ID: 34767312
[TBL] [Abstract][Full Text] [Related]
18. Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis.
Huang CF; Liang PC; Wang CW; Jang TY; Hsu PY; Tsai PC; Wei YJ; Yeh ML; Hsieh MY; Lin YH; Huang CK; Dai CY; Huang JF; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2024 Apr; 40(4):374-383. PubMed ID: 38234005
[TBL] [Abstract][Full Text] [Related]
19. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Loomba R; Jain A; Diehl AM; Guy CD; Portenier D; Sudan R; Singh S; Faulkner C; Richards L; Hester KD; Okada L; Li XJ; Mimms L; Abdelmalek MF
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1867-1876.e3. PubMed ID: 30448594
[TBL] [Abstract][Full Text] [Related]
20. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
